Most Claims Survive In Royalty Spat Over HPV Drug

Law360, New York (May 26, 2009, 12:00 AM EDT) -- A Delaware judge has let the majority of claims stand in a breach of contract suit brought against MedImmune Inc. and Glaxo Group Ltd. over human papillomavirus vaccine Cervarix, but has dismissed claims of unjust enrichment and unfair competition, among others.

Judge Joseph R. Slights III of the Superior Court for the State of Delaware allowed most of the 10 counts brought by the Boyce Thompson Institute for Plant Research to continue — including the central claim of breach of contract.

However, “in the face of...
To view the full article, register now.